WACC. Grey's Pharmaceuticals has a new project that will require funding of $12.1 million. The company has decided to pursue an all-debt scenario. Grey's has made agreements with four lenders for the needed financing. These lenders will advance the following amounts at the interest rates shown: Click on the Icon Lender Steven Yang Shepherd Bailey in order to copy its content into a spreadsheet. Amount Interest Rate $4,328,868 13% $3,695,316 11% $2,745,088 $1,330,728 9% 8% What is the weighted average cost of capital for the $12,100,000